[Aponal in the therapy of organic coronary blood flow disorders].
D003327:Coronary Disease / Q000188:drug therapy*; D003990:Dibenzoxepins / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007799:Lanatosides / Q000627:therapeutic use; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use
D003990:Dibenzoxepins; D007799:Lanatosides; D014665:Vasodilator Agents
Aponal in der Behandlung organisch bedingter koronarer Durchblutungsstörungen.